VHR Activators comprise a suite of chemical compounds that, through various biochemical mechanisms, contribute to the enhancement of VHR phosphatase activity. Elements like Zinc and Magnesium are critical as they directly stabilize the VHR structure, ensuring its catalytic domain is conformationally optimized for tyrosine dephosphorylation. Sodium Orthovanadate, while primarily a phosphatase inhibitor, can paradoxically increase VHR activity by inducing compensatory cellular responses that upregulate tyrosine phosphatase activity to maintain phosphoregulation. The presence of low-concentration Hydrogen Peroxide can modulate the redox state of VHR, leading to its activation, while Phenylarsine Oxide may interact with vicinal dithiols on VHR, enhancing its activity through alterations in the redox environment. Compounds such as Forskolin engage in signaling cascades that raise cAMP levels and activate PKA, which could indirectly enhance VHR's activity via phosphorylation of associated regulatory proteins.
Additionally, the use of phosphatase inhibitors like Okadaic Acid, Calyculin A, and Cantharidin, which target serine/threonine phosphatases, may lead to an indirect upsurge in VHR's tyrosine phosphatase activity as the cell attempts to recalibrate its phosphorylation equilibrium. Dithiothreitol (DTT) acts on a biochemical level to maintain the reducing environment crucial for the thiol-dependent catalytic mechanism of VHR, ensuring its active site is free from oxidative inactivation. The inhibition of other protein tyrosine phosphatases by chemicals like Sodium Stibogluconate and Pervanadate can result in a compensatory enhancement of VHR activity, as the cell modulates its signaling pathways to adapt to altered phosphatase dynamics, emphasizing the interconnected nature of cellular regulation where modifying one pathway can lead to the activation of another.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Zinc | 7440-66-6 | sc-213177 | 100 g | $48.00 | ||
Zinc ions act as essential cofactors for many phosphatases, including VHR. They stabilize the structure of the protein, ensuring proper catalytic activity. | ||||||
Sodium Orthovanadate | 13721-39-6 | sc-3540 sc-3540B sc-3540A | 5 g 10 g 50 g | $49.00 $57.00 $187.00 | 142 | |
As a phosphatase inhibitor, sodium orthovanadate’s presence can lead to competitive inhibition, which can indirectly enhance VHR activity through feedback mechanisms regulating phosphatase activity. | ||||||
Hydrogen Peroxide | 7722-84-1 | sc-203336 sc-203336A sc-203336B | 100 ml 500 ml 3.8 L | $31.00 $61.00 $95.00 | 28 | |
At low concentrations, hydrogen peroxide can act as a second messenger in redox signaling, potentially leading to oxidative activation of tyrosine phosphatases like VHR by reversing oxidation-sensitive inhibition. | ||||||
Phenylarsine oxide | 637-03-6 | sc-3521 | 250 mg | $41.00 | 4 | |
It can bind to vicinal dithiols, and by modifying the redox state of phosphatases like VHR, it may indirectly enhance its phosphatase activity. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin elevates cAMP, which activates PKA. PKA can phosphorylate regulatory proteins, which may indirectly upregulate VHR activity by altering its interactions or substrates. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
As an inhibitor of serine/threonine phosphatases, okadaic acid can cause a compensatory increase in tyrosine phosphatase activity, such as VHR, to maintain cellular phosphoregulation. | ||||||
Calyculin A | 101932-71-2 | sc-24000 sc-24000A | 10 µg 100 µg | $163.00 $800.00 | 59 | |
Inhibitor of serine/threonine phosphatases, which can lead to an indirect increase in tyrosine phosphatase activity to balance phosphorylation levels, potentially enhancing VHR activity. | ||||||
Cantharidin | 56-25-7 | sc-201321 sc-201321A | 25 mg 100 mg | $89.00 $279.00 | 6 | |
Cantharidin inhibits serine/threonine phosphatases, which could lead to a regulatory increase in tyrosine phosphatase activity, thereby potentially enhancing VHR activity. | ||||||